Related by context. All words. (Click for frequent words.) 70 myelodysplastic myeloproliferative diseases 69 hypereosinophilic syndrome 69 LHRH receptor positive 68 myelofibrosis polycythemia vera 68 leukemia AML 68 YONDELIS 68 myeloproliferative neoplasms 68 pediatric acute lymphoblastic 68 chronic eosinophilic leukemia 68 invasive candidiasis 68 receptor tyrosine kinase inhibitor 68 haematological cancers 68 thalidomide Thalomid 67 malignant lymphomas 67 relapsed MM 67 SNT MC# 67 Aviptadil 67 TTR amyloidosis 67 myeloproliferative disorders 67 vinca alkaloid 67 pan HDAC inhibitor 67 JAK inhibitors 67 CYT# potent vascular disrupting 66 atypical hemolytic uremic syndrome 66 transplantation HCT 66 lymphoid malignancies 66 cell lymphoma CTCL 66 bevacizumab Avastin ® 66 gastrointestinal stromal tumors GIST 66 leukemia ALL 66 transplantation HSCT 66 familial amyloidotic polyneuropathy FAP 66 mycosis fungoides 66 Myelodysplastic syndromes MDS 66 riociguat 66 OMP #R# 66 intra abdominal infections 66 Gleevec resistant 66 myeloproliferative diseases 66 constipation OIC 66 cMET 66 Sutent sunitinib 66 mutated KRAS gene 66 sJIA 66 refractory CLL 65 Romidepsin 65 RNAi therapeutic targeting 65 GW# [003] 65 hematological malignancy 65 Gleevec Glivec 65 Aplidin 65 systemic fungal infections 65 MELAS 65 Li Fraumeni Syndrome 65 leukaemias 65 relapsed leukemia 65 relapsed ALL 65 Sudhir Agrawal D.Phil 65 vWD 65 Myelodysplastic Syndrome MDS 65 essential thrombocythemia 65 malignant ascites 65 Cloretazine 65 trastuzumab Herceptin ® 65 primary hyperparathyroidism 65 hematological diseases 65 alkylating agent 65 aromatase inhibitors AIs 65 irinotecan oxaliplatin 65 basal cell carcinoma BCC 65 JAK2 inhibitor 65 Torisel temsirolimus 65 orally administered inhibitor 65 Evoltra ® 65 erlotinib Tarceva ® 65 HQK 65 investigational monoclonal antibody 65 essential thrombocythemia ET 65 Ribavirin causes 65 imatinib Gleevec 65 microtubule inhibitor 65 Anthracyclines 65 candidemia 65 micafungin 65 Sezary syndrome 65 hematological cancers 65 kidney urologic 65 AZT zidovudine Retrovir 65 Tigecycline 65 alpha interferons 65 Lenocta 65 haematologic malignancies 65 metastatic malignant melanoma 65 allogeneic hematopoietic stem cell 65 benign prostatic hypertrophy BPH 65 HBeAg negative 65 Squalamine 65 imatinib Gleevec ® 65 Kit CD# positive 64 lenalidomide dexamethasone 64 Vidaza azacitidine 64 cardio renal 64 erythropoietic 64 Chronic lymphocytic leukemia 64 neuroendocrine cancers 64 efalizumab 64 posaconazole 64 catheter occlusion 64 hematologic disorders 64 deletion 5q 64 demonstrated antitumor activity 64 humanised monoclonal antibody 64 DDP# 64 taxane resistant 64 leukemia CLL 64 INCB# [003] 64 anti angiogenic agents 64 taxane chemotherapy 64 eosinophilic asthma 64 lysosomal storage disease 64 gastrointestinal stromal tumors GISTs 64 Somatuline 64 Candida infection 64 ganciclovir 64 neurological manifestations 64 pulmonary hypertension PH 64 Systemic Lupus Erythematosus SLE 64 radiotherapeutic 64 Dacogen decitabine 64 HBeAg + 64 Ceflatonin 64 IAP inhibitors 64 combination antiretroviral therapy 64 Cx# [002] 64 inhibitor RG# 64 IgG1 antibodies 64 docetaxel Taxotere ® 64 neutropenia dehydration dyspnea 64 metastatic malignant 64 superficial bladder cancer 64 Liprotamase 64 idiopathic thrombocytopenic purpura ITP 64 TRAIL receptor antibodies 64 allogeneic HSCT 64 recurrent glioblastoma multiforme 64 K ras mutations 64 idiopathic myelofibrosis 64 Cutaneous T 64 immuno modulatory 64 metastatic neuroendocrine tumors 63 Fludara ® 63 SSc 63 treatmentof 63 papillary renal cell carcinoma 63 Factor VIIa 63 null responder 63 Acute myeloid leukemia AML 63 endocrine therapies 63 ara C 63 imatinib resistant 63 thrombocytopenic 63 subcutaneous immunoglobulin 63 heavily pretreated 63 IMA# 63 Azacitidine 63 epithelial tumors 63 refractory chronic lymphocytic 63 Virulizin ® 63 Acute Bacterial Sinusitis ABS 63 gastrointestinal stromal tumor GIST 63 Anthracycline 63 Lymphoid 63 pheochromocytoma 63 small molecule thrombopoietin 63 YONDELIS R 63 severe hypersensitivity reactions 63 stem cell transplantations 63 deferiprone 63 liposomal amphotericin B 63 EGFR tyrosine kinase inhibitors 63 Pafuramidine 63 Epratuzumab 63 steroid refractory 63 angiogenesis inhibition 63 polycythemia vera PV 63 Irinotecan 63 Annamycin 63 polycythemia vera essential thrombocythemia 63 Severe Primary IGFD 63 hepatic metastases 63 trabectedin 63 Friedreich Ataxia FRDA 63 miglustat 63 immunocompetent patients 63 Akt inhibitor 63 cancer mCRC 63 pediatric Crohn disease 63 bladder carcinoma 63 TTR gene 63 Bezielle 63 dyslipidemias 63 Letairis ambrisentan 63 telomerase therapeutic 63 secondary amenorrhea 63 hemorrhagic cystitis 63 metastatic renal cell carcinoma 63 THALOMID ® 63 p# inhibitor 63 sunitinib malate 63 R Saizen R 63 VEGF inhibitors 63 Surgical resection 63 metastatic colorectal 63 anthracycline taxane 63 Xanafide 63 alvespimycin 63 hematologic malignancies 63 Lenalidomide 63 Actinic Keratosis 63 MKC# MT 63 sodium thiosulfate STS 63 Mitoxantrone 63 advanced metastatic renal 63 sorafenib Nexavar 63 Certolizumab pegol 63 herpetic keratitis 63 Anti VEGF 63 anthracycline chemotherapy 63 indinavir Crixivan 63 lymphoma leukemia 63 signal transduction inhibitors 63 immunological diseases 63 tyrosine kinase inhibitor TKI 63 haematopoietic stem cell 63 IMiDs ® compound 63 ® lenalidomide 63 Fludarabine 63 rALLy 63 Clolar ® 63 LHRH antagonists 63 refractory acute myeloid 63 hypomethylating agents 63 Neupogen ® 63 lipid lowering agents 63 MYLOTARG 63 Revlimid lenalidomide 63 anthracyclines taxanes 63 skeletal metastases 63 de novo AML 63 tiuxetan 63 nucleoside analogues 63 Immunotherapeutic 63 MAGE A3 ASCI 63 myeloproliferative 63 adriamycin 63 depsipeptide 63 radezolid 63 NMDA antagonists 63 Zorbtive TM 63 nucleoside analog 63 hepatorenal syndrome 63 Gleevec imatinib mesylate 63 LEUKINE 63 imatinib resistance 63 Peginterferon alfa 2b 63 Cell Lymphoma CTCL 62 gastrointestinal stromal tumors 62 esophageal candidiasis 62 dasatinib Sprycel 62 bortezomib Velcade 62 aripiprazole Abilify 62 lenalidomide Revlimid R 62 Dacogen injection 62 paclitaxel Taxol R 62 Nexavar sorafenib 62 Gleevec imatinib 62 MGd 62 alefacept 62 recurrent glioma 62 Hematologic 62 nucleoside analogs 62 HeFH 62 cutaneous T 62 histologies 62 hematological malignancies 62 OHR/AVR# 62 proteasome inhibitor 62 OMNARIS HFA 62 R lenalidomide 62 rheumatoid arthritis psoriatic arthritis 62 Leukemias 62 denileukin diftitox 62 chronic myeloid 62 vascular disrupting agents 62 vidofludimus 62 colorectal carcinoma 62 immunomodulation 62 humanized monoclonal 62 metastatic gastric 62 paroxysmal nocturnal hemoglobinuria 62 prokinetic agent 62 Eraxis 62 idarubicin 62 hematologic cancers 62 MEK inhibitors 62 GRN# 62 ISTODAX ® 62 monoclonal antibody conjugated 62 Omacetaxine 62 SPRYCEL ® 62 cetuximab Erbitux R 62 tigecycline 62 acyclovir Lauriad R 62 heparin induced thrombocytopenia 62 relapsed ovarian cancer 62 chronic myocardial ischemia 62 therapeutic regimens 62 Navelbine ® 62 TKI therapy 62 cetuximab Erbitux ® 62 EGFR inhibitors 62 phase III isavuconazole 62 adalimumab Humira 62 Personalized Immunotherapy 62 Orally administered 62 posterior uveitis 62 serous ovarian cancer 62 echinocandin 62 galiximab 62 atypical Hemolytic Uremic Syndrome 62 Patients Treated With 62 G6PD deficiency 62 mTOR inhibitors 62 Cetrorelix 62 antisense inhibitors 62 TNF alpha selectively neutralizing 62 calcineurin inhibitors 62 secondary hyperparathyroidism 62 Glucocorticoids 62 monoclonal anti 62 acetonide FA 62 relapsed acute myelogenous 62 oxaliplatin Eloxatin 62 oncological indications 62 relapsed multiple myeloma 62 interferon IFN 62 dasatinib Sprycel ® 62 demethylating agent 62 Velcade bortezomib 62 antibody MAb 62 pancreatic neuroendocrine tumors 62 Golimumab 62 protease inhibitors PIs 62 haematologic 62 TheraCIM 62 tubulin inhibitor 62 trastuzumab Herceptin R 62 itraconazole Sporanox 62 psoriatic arthritis PsA 62 trastuzumab Herceptin 62 Actimmune ® 62 decompensated liver disease 62 FLT3 62 Saizen ® 62 ADP receptor antagonist 62 thrombolytic agent 62 Torisel 62 lumiliximab 62 Acute myeloid leukemia 62 investigational therapies 62 AEG# 62 cidofovir 62 LHON 62 immunopathology 62 MYCAMINE 62 taxane therapy 62 serologically active systemic lupus 62 Aflibercept 62 complement inhibitor eculizumab 62 TroVax ® 62 fludarabine cyclophosphamide 62 thetreatment 62 HER2 positive metastatic breast 62 osteosarcoma Ewing sarcoma 62 Phase #b/#a clinical 62 Cancidas 62 OvaRex ® MAb 62 Complicated Skin 62 Toxicities 62 ATTR CM 61 calcineurin inhibitor 61 myelodysplastic syndrome MDS 61 cisplatin gemcitabine 61 xenograft models 61 d4T stavudine Zerit 61 CA4P 61 unresectable recurrent 61 PNP inhibitor 61 TELINTRA 61 HRPC 61 Deferiprone 61 OZURDEX ® 61 immunomodulatory therapy 61 Amrubicin 61 Chronic Myeloid Leukemia 61 novel VDA molecule 61 Rituxan rituximab 61 cystic fibrosis chronic pancreatitis 61 basiliximab 61 pegylated liposomal doxorubicin 61 neovascular diseases 61 immunocompromised patients 61 Erlotinib 61 Lubiprostone 61 histone deacetylase inhibitor 61 metastatic GIST 61 HuMax CD4 61 non metastatic osteosarcoma 61 noninfectious uveitis 61 decitabine 61 refractory anaplastic astrocytoma 61 HIV integrase inhibitors 61 idiopathic thrombocytopenic purpura 61 gefitinib Iressa 61 TMP SMX 61 Exelixis XL# 61 lintuzumab SGN 61 Fibrillex TM 61 Hervé Hoppenot President 61 chimeric monoclonal antibody 61 sunitinib Sutent 61 immune modulating 61 ß blockers 61 tumor malignancies 61 ocular disorders 61 CEQ# 61 A3 adenosine receptor 61 INVANZ 61 Nilotinib 61 Onalta TM 61 overactive bladder syndrome 61 oncologic diseases 61 Voreloxin 61 elacytarabine 61 JAK1 61 myeloid 61 multiple myeloma MM 61 Chronic lymphocytic leukemia CLL 61 zidovudine AZT 61 myelodysplastic syndromes MDS 61 post herpetic neuralgia PHN 61 herpes zoster shingles 61 selective kinase inhibitor 61 vaccine GRNVAC1 61 MabThera Rituxan 61 alkylating 61 fibrosing 61 transthyretin TTR mediated amyloidosis 61 acute coronary syndromes ACS 61 medullary thyroid cancer 61 hematological disorders 61 oropharyngeal candidiasis OPC 61 THALOMID R 61 caspofungin 61 Romiplostim 61 Atypical Hemolytic Uremic Syndrome 61 potassium binder 61 dermatofibrosarcoma protuberans 61 homozygous FH 61 vapreotide acetate 61 biliary tract cancer 61 pouchitis 61 mixed hyperlipidemia 61 macrolide antibiotic 61 metaglidasen 61 CytoFabTM 61 PDE# inhibitors 61 Gefitinib 61 HIV coinfected 61 non alcoholic steatohepatitis 61 TYZEKA 61 Ozarelix 61 visceral metastases 61 BrachySil TM 61 Myelodysplastic syndromes 61 pancreatic NET 61 velafermin 61 Rebif ® 61 refractory gout 61 psoriasis rheumatoid arthritis 61 targeting CD# 61 ELACYT 61 tuberous sclerosis TS 61 intracranial hemorrhage ICH 61 HER2 overexpression 61 haematological 61 Vandetanib 61 Familial Adenomatous Polyposis FAP 61 Clofarabine 61 histone deacetylase HDAC inhibitors 61 Lixivaptan 61 malignant pleural mesothelioma 61 multiple sclerosis psoriasis 61 pancreatic adenocarcinoma 61 CLL SLL 61 CellCept mycophenolate mofetil 61 protease inhibitor PI 61 Altastaph 61 IL# PE#QQR 61 paclitaxel Taxol ® 61 INTEGRILIN R 61 atopic dermatitis eczema 61 Pazopanib 61 Zavesca R 61 TransVax ™ 61 unresectable HCC 61 mGluR5 NAM 61 LHRH agonist 61 bexarotene 61 allogeneic bone marrow 61 drug ISA# 61 cutaneous T cell 61 situ CIS 61 malignant neoplasms 61 pancytopenia 61 Noxafil 61 Traficet EN 61 arsenic trioxide injection 61 imatinib mesylate 61 metastatic RCC 61 M2 subunit 61 immunodeficiency disorders 61 reslizumab 61 phase IIb trial 61 eculizumab therapy 61 cytoreduction 61 leukemia multiple myeloma 61 HIV HCV coinfected 61 lung carcinomas 61 Tamibarotene 61 anti angiogenic therapy 61 rheumatologic 61 MDS MPD 61 Myocet 61 lung cancer NSCLC 61 RhuDex ® 61 ENMD # 61 hyperphenylalaninemia HPA due 61 Staphylococcus aureus infections 61 basal cell nevus syndrome 61 ATTR 61 chronic GVHD 61 Juvenile Idiopathic Arthritis 61 Pemetrexed 61 cytostatic 61 mutated K ras 61 transthyretin amyloidosis 61 refractory Hodgkin 61 Angioedema 61 metastatic renal 61 anti secretory 61 headache abdominal pain 61 HERCEPTIN 61 lymphomas leukemias 61 G CSFs 61 beta 1a 61 Actemra tocilizumab 61 CANCIDAS 61 tumors GIST 61 Proxinium TM 61 dual endothelin receptor antagonist 61 gastric adenocarcinoma 61 recurrent glioblastoma 61 Enzyme Replacement Therapy 61 TNF alpha antagonist 61 Pemphigus 61 Thiovir 61 BCR ABL inhibitor 61 non splenectomized 61 chronic periodontitis 61 GTC recombinant human 61 selective modulator 61 NNRTIs 61 Myelofibrosis 61 Eculizumab 61 fallopian tube carcinoma 61 Decitabine 61 Valopicitabine 61 hepatitis C HCV 61 interleukin IL -# 61 tumor necrosis 61 multicentric 61 hA# 61 chronic lymphocytic leukemia CLL 61 anticancer therapies 61 lymphoproliferative disorders 61 Vorinostat 61 unresectable tumors 61 chronic immune thrombocytopenic 61 Aplidin R 61 myeloproliferative neoplasms MPNs 61 Pseudomonas aeruginosa infections 61 unknown etiology 61 candidiasis 61 JAK inhibitor 61 sodium stibogluconate 60 DepoCyt 60 GRASPA ® 60 ovarian breast 60 NovaBay Aganocide compounds 60 Acute Myelogenous Leukemia AML 60 ZACTIMA 60 homozygous familial hypercholesterolemia 60 NSAID induced 60 radiochemotherapy 60 TEMODAL 60 AQ4N 60 biologic DMARD 60 Tyrima 60 lucinactant 60 coagulation disorders 60 opioid induced constipation OIC 60 invasive aspergillosis 60 palifermin 60 hematological indications 60 relapsed refractory 60 Fingolimod 60 EGFR HER2 60 Dasatinib 60 Mitomycin C 60 panobinostat 60 microtubule targeting 60 Afatinib 60 familial hypercholesterolemia FH 60 castrate resistant prostate cancer 60 MOVIPREP R 60 PAOD 60 intravesical therapy 60 Campath alemtuzumab 60 Allogeneic 60 indolent NHL 60 Proquin XR 60 metastatic bladder 60 romidepsin 60 trans retinoic acid 60 etanercept Enbrel 60 SUPPRELIN R LA 60 smoldering myeloma 60 VP# [004] 60 effector function 60 patientswith 60 post transplant lymphoproliferative 60 SYN# 60 lymphoma subtypes 60 tyrosine kinase inhibitor 60 hemoglobinopathies 60 Everolimus 60 ALN PCS 60 Pneumocystis carinii pneumonia 60 taxane refractory 60 sublingual tablets 60 Carbamazepine 60 Calcitonin 60 diabetic neuropathic pain 60 colorectal liver metastases 60 Glioblastoma Multiforme 60 Blinatumomab 60 lomitapide 60 corticosteroid dexamethasone 60 BioNumerik 60 nephropathic cystinosis 60 HCV protease inhibitors 60 staphylococcal infections 60 Pimavanserin 60 Investigational Treatment 60 pemphigus vulgaris 60 diseases fat malabsorption 60 Cerebril TM 60 hypertrophic scars 60 Onconase 60 Lambert Eaton Myasthenic 60 dermatological disorders 60 evaluating tivozanib 60 TNF antagonist 60 HBeAg positive patients 60 antimitotic 60 Neulasta ® 60 clevidipine 60 standard chemotherapy regimens 60 paroxysmal nocturnal hemoglobinuria PNH 60 forodesine 60 miconazole Lauriad ® 60 bevacizumab Avastin R 60 Intravenous immunoglobulin 60 receiving VELCADE 60 refractory metastatic 60 Shigamabs ® 60 gonococcal 60 portal vein thrombosis 60 gemcitabine Gemzar 60 VDAs 60 pancreatic islet cell 60 TNF blocking 60 mda 7 60 Fabry Disease 60 interferon gamma 1b 60 immunosuppressed patients 60 hepatitis B HBV 60 ceftazidime 60 multitargeted 60 novel histone deacetylase 60 olaparib 60 Combo Stent 60 Selective Internal 60 relapsed refractory multiple myeloma 60 thrombocytosis 60 LHRH agonists 60 leiomyomas 60 Solazed TM 60 Tarceva TM 60 cediranib 60 Aryplase 60 daptomycin 60 severe malignant osteopetrosis 60 antiandrogens 60 asplenia 60 HGS# 60 severe hepatomegaly 60 gastroesophageal junction 60 ATG Fresenius S 60 Sclerosing 60 stage IIIB 60 IMiDs ® 60 Opportunistic infections 60 allogeneic hematopoietic cell 60 superficial basal cell carcinoma 60 ThermoDox R 60 acute GvHD 60 antiangiogenic drugs 60 overlapping toxicities 60 AVASTIN 60 ovarian carcinoma 60 refractory cutaneous T 60 Dalbavancin 60 oral picoplatin 60 tumor lysis syndrome 60 cyclophilin inhibitors 60 mRCC 60 aHUS 60 HuLuc# 60 lexidronam injection 60 antineoplastic 60 Anaplastic 60 peptide conjugated 60 anticancer therapy 60 E1 INT TM 60 mecasermin 60 abacavir Ziagen 60 samarium Sm 60 Candida infections 60 Metastatic breast cancer 60 neutropenic patients 60 vinca alkaloids 60 GARDASIL ® 60 myeloablative 60 NXL# 60 diagnostic molecular imaging 60 photodisinfection 60 CTAP# Capsules 60 Genasense ® 60 Etanercept 60 oral prodrug 60 MDS AML 60 AA Amyloidosis 60 Zemplar Capsules 60 stage IIIb IV 60 rheumatological 60 hemolytic anemia 60 Vicinium TM 60 ganetespib 60 Luteinizing Hormone Releasing Hormone 60 rFactor XIII 60 hepatocellular carcinomas 60 Methylnaltrexone 60 Potelligent Technology 60 Hodgkin lymphoma HL 60 antimetabolite 60 anti leukemic 60 chronic HBV 60 carcinoid 60 Copegus ribavirin 60 TYGACIL 60 haematopoietic 60 cytotoxic chemotherapy 60 Darinaparsin 60 immune modulatory 60 Zavesca 60 protein kinase inhibitor 60 TBC# 60 fistulizing Crohn disease 60 multi kinase inhibitor 60 THALOMID 60 JAK2 kinase 60 Renal impairment 60 included exfoliative dermatitis 60 rheumatic diseases 60 ISTODAX 60 tyrosine kinase inhibitors TKIs 60 Stanate R 60 Recombinant interferon alpha 60 DOXIL 60 uric acid lowering 60 including eniluracil ADH 60 BEXXAR Therapeutic Regimen 60 Mepact 60 hyperoxaluria 60 imatinib therapy 60 chronic idiopathic thrombocytopenic purpura 60 cIAI 60 LymphoStat B belimumab 60 invasive fungal infections 60 Anidulafungin 60 Antitumor Activity 60 radiolabeled TM# 60 AKT inhibitor 60 recurrent NSCLC 60 histone deacetylase HDAC inhibitor 60 primary immunodeficiency PI 60 bevacizumab Avastin 60 PGL# 60 Acute Radiation Syndrome 60 B CLL 60 pathophysiological effects 60 Alessandro Riva 60 diarrhea predominant irritable 60 multikinase inhibitor 60 EGFR antibodies 60 occlusive disease 60 prostate carcinoma 60 commercialize deforolimus 60 Elagolix 60 JAK2 inhibitors 60 Hepatocellular Carcinoma HCC 60 hyperplasia BPH 60 Systemic lupus erythematosus SLE 60 angiogenesis inhibitor 60 gastric pancreatic 60 HDAC Inhibitor 60 recombinant enzyme 60 doxorubicin Adriamycin 60 Alemtuzumab 60 severe hypercholesterolemia 60 pegfilgrastim 60 deep venous thromboses 60 Remicade infliximab 60 metastatic sarcoma 60 cutaneous squamous cell carcinoma 60 mertansine 60 Venous thromboembolism 60 Fluconazole 60 juvenile idiopathic arthritis JIA 60 QUADRAMET R 60 lipid lowering therapies 60 ADAMTS# 60 Microplasmin 60 autologous transplants 60 lung pancreatic 60 Modrenal R 60 chemotherapy cisplatin 60 Diabetic Macular Edema 60 treat benign prostatic 60 Gonal f ® 60 Triapine 60 autoimmune hemolytic anemia 60 advanced carcinoid 60 Alocrest 60 flavopiridol 60 IMiDs R 60 G#DT 60 Epidermal Growth Factor Receptor 60 OMP #M# 60 Renal Cell Carcinoma RCC 59 Inflammatory Diseases 59 IOP lowering 59 cystic fibrosis bronchiectasis 59 PEGylated Fab fragment 59 IPAH 59 Inhaled nitric oxide 59 VNP#M 59 oropharyngeal candidiasis 59 PDE4 inhibitor 59 recombinant interferon 59 neurovascular diseases 59 Intra arterial 59 ALT flares 59 prostate cancer CRPC 59 investigational compounds 59 methicillin susceptible Staphylococcus aureus 59 membranous nephropathy 59 hypophosphatasia 59 formerly LymphoStat B 59 Xelox 59 follicular lymphoma FL 59 RAPTIVA 59 FOLOTYN ® 59 APTIVUS 59 ophthalmology oncology 59 histologically confirmed 59 renal cell carcinomas 59 novel peptide 59 inhaled bronchodilators 59 thromboembolic disease 59 FUSILEV enhances 59 headache nausea diarrhea 59 CIMZIA TM certolizumab pegol 59 Ranibizumab 59 toenail onychomycosis 59 ALN HPN 59 Sapacitabine 59 T1DM 59 GERD migraine headaches 59 TTF Therapy 59 multiple sclerosis rheumatoid arthritis 59 cytomegalovirus infection 59 targeted antifolate 59 Novartis Gleevec 59 humanized monoclonal antibodies 59 HSP# inhibitor 59 chronic granulomatous disease 59 Carcinoid tumors 59 PDGFR 59 docetaxel Taxotere R 59 aggressive systemic mastocytosis 59 Clostridium difficile associated 59 tropism testing 59 SinuNase TM 59 cardiometabolic disorders 59 hematologic tumors 59 intravenous bisphosphonates 59 renal tumors 59 painful diabetic neuropathy 59 Hurler syndrome 59 maximally tolerated lipid lowering 59 p# MAP kinase inhibitor 59 IBS C 59 Acute Radiation Syndrome ARS 59 Solesta 59 neutropenia thrombocytopenia 59 Myozyme alglucosidase alfa 59 Neovascular Age Related Macular 59 Paraplatin ® 59 Lenocta TM 59 cilengitide 59 Litx 59 thymectomy 59 Sebivo 59 seminoma 59 Genentech Rituxan 59 K RAS 59 Alequel 59 Bronchiectasis 59 Cytomegalovirus CMV 59 unresectable liver cancer 59 Valortim R 59 Combivir Kivexa 59 Symadex 59 advanced metastatic prostate 59 pharmacologic therapies 59 gastrointestinal mucositis 59 Enzastaurin 59 prostate cancer HRPC 59 azacytidine 59 glucocorticoid induced osteoporosis 59 oncolytic virus therapy 59 flutamide 59 cinacalcet 59 Waldenstrom macroglobulinemia 59 Maribavir 59 secretory diarrhea 59 ribavirin RBV 59 immunosuppressive therapies 59 Platinol ® 59 cytopenias 59 relapsing remitting MS RRMS 59 Hereditary angioedema HAE 59 PEGylated interferon 59 bladder ovarian 59 anemia neutropenia 59 Reminyl galantamine 59 Granulocyte Colony Stimulating Factor 59 erlotinib Tarceva 59 TRPV1 agonist 59 Herceptin trastuzumab 59 EOquin 59 hematologic toxicity 59 induce orthostatic hypotension 59 PKC# 59 imipenem 59 immunocompetent